🕵️ Biomx Inc. ($PHGE)
SEC insider & ownership activity, last 12 months · CIK 1739174 · every row links its SEC filing
Insider sell value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Jun 10, 2026.
Insider flow
0 buyers, $0 (0 lots) · 1 seller, value withheld pending verification (7 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Yeganeh Reuven | 0 | – | 7 | value withheld pending verification | Mar 17, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| PYU PYU Capital, LLC | 20.0% | 13D | Dec 26, 2025 | filing ↗ | |
| Reuven Yeganeh | 20.0% | 13D | Dec 26, 2025 | filing ↗ | |
| Nantahala Capital Management, LLC | 7.1% | 13G | Aug 14, 2026 | filing ↗ | |
| Wilmot B. Harkey | 7.1% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Mack | 7.1% | 13G | Aug 14, 2026 | filing ↗ | |
| Pod Sarl | 5.2% | 13G | May 14, 2026 | filing ↗ | |
| Water IO Ltd. | exited | 13D | Sep 15, 2026 | filing ↗ | |
| T3 Defense Inc. | exited | 13D | Sep 15, 2026 | filing ↗ | |
| Menachem Shalom | exited | 13D | Sep 15, 2026 | filing ↗ | |
| Star 26 Capital Inc. | exited | 13D | Sep 15, 2026 | filing ↗ | |
| Cystic Fibrosis Foundation | exited | 13G | Aug 20, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Charter/bylaw changes (5.03) | Sep 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 11, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2026 | filing ↗ |
| Other events (8.01) | Sep 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 1, 2026 | filing ↗ |
| Other events (8.01) | Aug 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 28, 2026 | filing ↗ |
| Other events (8.01) | Aug 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 28, 2026 | filing ↗ |
| Shareholder vote (5.07) | Aug 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 25, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 5, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 27, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |
| Other events (8.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Auditor change (4.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Delisting notice (3.01) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |